In the chaos of the ICU, guessing wrong on fluid management can kill a patient. ImaCor isn't just selling ultrasound equipment; they're selling certainty. They've built a specialized platform for hemodynamic ultrasound that targets the single most critical variable in shock: preload.

"They aren't trying to be the next Medtronic. They are building a niche monopoly on the 'holy grail' of ICU decision-making."

With only 2,470 monthly visits, ImaCor is not playing the volume game. This is high-consideration B2B medical sales. Every visitor is likely a clinician, hospital procurement officer, or researcher. The 54% organic share indicates strong word-of-mouth and reputation; they aren't buying clicks, they are earning them through clinical validation.

• Precision over scale: A $5.5M revenue on 22 employees suggests high average contract value.
• Founder-led expertise: CEO Scott Roth serves dual roles as Chief Medical Officer, bridging the gap between tech and bedside care.
• Tech stack simplicity: Using jQuery and Bootstrap suggests a focus on reliability and speed over flashy frontend animations—a necessity for critical care environments.